Maria Mercau @mariamercau@social.cleverlibre.org

Moreover, inhibition of RPE inflammation with Ruxolitinib, a JAK1/2 inhibitor, mitigated the severity of the aggressive, early-onset retina degeneration phenotype observed in Mertk knock out mice.